Effect of deferoxamine therapy on insulin resistance in end-stage renal disease patients with iron overload.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia

Volumn 25, Issue 4, 2014, Pages 808-813

  Alnahal, Alsayed Ahmed ^a   Tahan, Magdy ^b   Fathy, Aymen ^b   Fathy, Tamer ^b  

^a ZAGAZIG UNIVERSITY   (Egypt)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DEFEROXAMINE; FERRITIN; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN; IRON CHELATING AGENT;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; IRON OVERLOAD; MALE; METABOLISM; MIDDLE AGED; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY; RISK FACTOR; TIME; TREATMENT OUTCOME;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; DEFEROXAMINE; FEMALE; FERRITINS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; IRON CHELATING AGENTS; IRON OVERLOAD; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84907424942     PISSN: 13192442     EISSN: None     Source Type: Journal    
DOI: 10.4103/1319-2442.135025     Document Type: Article

References (0)